- change ups
Global Food Protection Institute names Julia Bradsher CEO
The Global Food Protection Institute in Battle Creek has announced the appointment of Julia Bradsher as president and CEO.
Bradsher previously served as CEO of the Food Allergy & Anaphylaxis Network, where she was responsible for the strategic direction and overall management of the world’s largest nonprofit organization providing information about food allergies to the media, schools, health professionals, pharmaceutical companies, the food industry, and government officials, as well as all those affected by food allergies and anaphylaxis.
At GFPI, Bradsher succeeds Stephen Benoit, the founding president, who will continue as a member of the board of directors. As head of the GFPI, Bradsher will also serve as president and CEO of the International Food Protection Training Institute.
The Global Food Protection Institute, which describes itself as a “community of action advancing food protection,” was founded in 2009 through a major initial grant from the W.K. Kellogg Foundation. Joan Bowman of Battle Creek Unlimited, a regional economic development agency, said Battle Creek Unlimited first proposed the concept of a new organization capitalizing on the food science heritage of Battle Creek to provide training for food safety specialists on a worldwide scale.
Today, GFPI serves as a connection for the social, political, economic and environmental driving forces that influence the adoption of food protection policies and practices leading to improved public health.
Two of the GFPI’s global initiatives are contained within the IFPTI, which is building the training infrastructure for the national integrated food safety system known as Emerging Technology Accelerator, advancing the development of new food protection technologies. The other global initiative is Imagined Food Futures, which is facilitating the adoption of policies and practices that will lead to improved public health.
“Julia’s success as a nonprofit executive in the public health policy, regulation and advocacy sectors, as well as her biopharmaceutical industry experience, will be invaluable as she leads GFPI through the next phase of its growth and development,” said Benoit. “I am extremely pleased we were able to attract an executive of her stature to continue the work of the Institute and its family of global initiatives.”
Bradsher also has served as head of marketing and market research for Dey LP, a subsidiary of Mylan Inc., which develops treatment for respiratory diseases, severe allergic reactions and psychiatric disorders. She was also a director at Decision Resources, a provider of analysis and data for the biopharmaceutical industry.
“I’m thrilled to have been selected to lead this groundbreaking organization dedicated to improving public health,” said Bradsher. “GFPI has led the way in building the training infrastructure for the national integrated food safety system through its IFPTI initiative, and I am looking forward to building on this success through the additional growth of its ETA and IFF initiatives.”
Bradsher has extensive knowledge of anaphylaxis, a potentially fatal allergic reaction. At Dey, she led the marketing and strategic planning for all Dey pharmaceutical products, including EpiPen, an auto-injector device containing epinephrine, a drug that can stop an anaphylactic reaction. She has also conducted research on the needs of those who suffer from food allergy and anaphylaxis.
She has authored 10 journal articles and seven book chapters, and has held research and faculty appointments in private research institutes and universities.